Applied Nanoscience
Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development
company, today confirmed an expansion of its technical staff by adding three
key positions to ensure a successful production scale-up and supply of the company's
proprietary antimicrobial NanoFense(TM) technology, a U.S. patent pending nanoparticle
formulation.
ANI recently announced a joint venture agreement with an Asia Pacific region
partner to begin production of the NanoFense Protective Face Mask for launch
to non-U.S. markets. Initial production will be 30,000 masks/day with the capability
of increasing up to 90,000 masks/day on newly installed automatic equipment
which operates 7 days a week. ANI will supply the NanoFense formulation premixed
under their label.
"We are extremely fortunate to add a world class nano-silver expert along
with two dedicated personnel for this critical component of our joint venture
product launch. The importance of the pilot plant design and reliable daily
production requirements cannot be overstated. We have accomplished this with
the dedicated commitment of a very talented team and will be positioned to consistently
supply enough formulation to 'coat' approximately 120,000 disposable NanoFense
Protective Face Masks/day should the demand require. A 7-day production week
equates to roughly 3.5 million masks per month," stated Thomas K. Allen,
President and CEO, ANI.
The disposable NanoFense Protective Face Mask will be sold in many of the countries
where ANI has issued patents protecting their broad NEFT(TM) platform. The patent
coverage includes three main methods of associating nanoparticles with filter
media: (1) coating the filter media with a powder of nanoparticles, (2) impregnating
the nanoparticles into the filter media, and (3) having pellets of nanoparticles
located adjacent to the filter media.